Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphatic Metastasis 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Indocyanine Green 7Surgical Procedures, Operative 5Lymph Node Excision 5Radiotherapy, Intensity-Modulated 4Radiotherapy 4Radiosurgery 4Cisplatin 4gadofosveset trisodium 2TP protocol 2Sentinel Lymph Node Biopsy 2Radiation Dose Hypofractionation 2Magnetic Resonance Spectroscopy 2Electroporation 2Conversion to Open Surgery 2Control Groups 2Chemotherapy, Adjuvant 2Chemoradiotherapy 2Artificial Intelligence 2tislelizumab 1sarcolipin 1lncRNA LNMAT1, human 1gewf solution 1fluoroazomycin arabinoside 1X-Rays 1Technetium-99 1Technetium 1Surgery, Computer-Assisted 1Spectrum Analysis 1Specimen Handling 1Robotic Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphatic Metastasis × Cobalt-60 × Clear all
NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡